Persistent Opioid Use After Sarcoma Treatment Explored Among Youth
Twenty-three percent of AYAs with sarcoma who were previously opioid-naive and use opioids during treatment have new persistent opioid use after treatment.
Twenty-three percent of AYAs with sarcoma who were previously opioid-naive and use opioids during treatment have new persistent opioid use after treatment.
After a school shooting in Uvalde, Texas, Tali Raviv, MD, associate director of the Center for Childhood Resilience at Ann & Robert H. Lurie Children’s Hospital in Chicago, discussed strategies for clinicians to help their clients manage high-profile incidents of violence.
During the first pandemic year, there were increases in the proportion of pediatric patients presenting to hospital with suicidal ideation/suicidal attempts, depression, anxiety, eating disorders, substance use disorders, and obsessive compulsive and related disorders.
Stress, isolation, and untreated mental health struggles can have a profound effect on people. As a result, early intervention is needed for improved mental health care. How are adolescents and young adults doing with their mental health, and what is the state of youth mental health care?
The researchers compared depression and anxiety scores before and during the pandemic.
The prevalence of adolescent vaping is 8.6% in 47 lower-middle, upper-middle, and high-income countries; the prevalence of vaping is 1.7%.
This study was a secondary analysis of the public-use data from the 2012 Canadian Community Health Survey-Mental Health which was a cross-sectional survey focusing on social and economic determinants of mental health.
Participants of the Adolescent Social Development and Sleep study which recruited patients in Texas between 2019 and 2020 before local quarantine restrictions were asked to participate in this study about COVID-19 behaviors and opinions.
Investigators extracted data from the Adolescent Behavior Cognition Development (ABCD) study, a longitudinal cohort study that enrolled children aged 9 to 10 years at baseline from 21 sites around the US.
Many young adults with a major depressive episode (MDE) do not receive any treatment, with cost being the most prominent barrier.